Page 216 - Read Online
P. 216

Review

            Diet and nutrition therapy in pre-liver transplant patients



            Neha Bakshi, Kalyani Singh
            Lady Irwin College, Department of Foods and Nutrition, University of Delhi, New Delhi 110001, India.


                 ABSTRACT
                 Malnutrition is universally prevalent among pre-liver transplantation patients. Malnutrition among cirrhotic patients
                 had been associated to increased morbidity and mortality rates. Also, severely malnourished patients before the
                 transplant surgery have a higher rate of complications and a decreased overall survival rate after liver transplantation.
                 In  light of  the high incidence  of  malnutrition and associated complications, it  is essential to  initiate treatment as
                 early as it is assessed. This review addresses the aetiologies of malnutrition and appropriate treatment strategies to
                 correct it in pre-liver transplant phase. Treatment should focus on maintaining nutrient intake and correcting various
                 nutritional deficiencies. The dietician plays an integral role as part of the transplant team by providing appropriate
                 nutrition therapy for solving various nutrition problems.
                 Key words: End stage liver disease; liver transplantation; pre-liver transplant

            Corresponding Author:
            Ms. Neha Bakshi, Lady Irwin College, Department of Foods and Nutrition, University of Delhi, Sikandra Road, Mandi House, New Delhi 110001,
            India. E-mail: nehabakshi.9@gmail.com
            Received: 30-01-2016, Accepted: 04-07-2016


            INTRODUCTION                                      CONSEQUENCES OF PREOPERATIVE MALNUTRITION
                                                              ON LIVER TRANSPLANTATION OUTCOME
            Liver transplantation (LT) revolutionized the management of
            liver disease. LT is the only option for those with end stage   Survival in cirrhosis decreases according to the severity of
                                                                            Preoperative hypermetabolism and body
                                                                        [10,11]
                                                              malnutrition.
            liver disease (ESLD).  According to Institute of Health Metrics   cell mass depletion was proven to be better predictors of
                           [1]
            and Evaluation of Global Burden of Disease, deaths from   the outcome of LT than the traditional Child-Pugh score.
                                                                                                           [12]
            cirrhosis in all age groups is ranked 12th globally and 19th in   Undernutrition may induce an exaggerated cytokine
            South Asia in 1990 and was ranked 12th globally and 11th in   response favouring postoperative systemic inflammatory
            South Asia in the year 2010. Hence, an increasing death from   response  syndrome  and multi-organ  failure in  these
                                                              patients.  Zinc deficiency is a precipitating factor for hepatic
                                                                     [13]
            cirrhosis is seen in South Asia over a period of time. [2]
                                                              encephalopathy.  Deficiencies of water-soluble vitamins (B
                                                                           [14]
                                                              and C) and fat soluble vitamins (A, E, D, and K) may occur
            METABOLIC CHANGES IN ESLD                         in patients with cirrhosis which increases the susceptibility
                                                              of cell membranes to lipid peroxidation.  Low retinol levels
                                                                                             [8]
            Various metabolic changes that occur in ESLD patients are   leads to an increased risk of developing hepatocellular
            presented in Table 1 [3-7]  which affect the nutrition state of   carcinoma. [15]
            pre-LT recipients. These factors are inadequate dietary
                                                              Hence, careful nutritional assessment of candidates for LT
            intake, increased intestinal protein losses, malabsorption,
                                                              is very important because the nutritional status of these
            low protein synthesis, hypermetabolism and disturbed   patients may ultimately influence morbidity and mortality.
            substrate utilization. [8,9]                      Unfortunately, no gold standard exists to determine the extent
                                                              of malnutrition in this population.  An suitable nutritional
                                                                                         [16]
                            Access this article online
                                             Quick Response Code  This is an open access article distributed under the terms of the Creative
              Website:                                         Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows
              http://www.hrjournal.net/                        others to remix, tweak, and build upon the work non-commercially, as long as the
                                                               author is credited and the new creations are licensed under the identical terms.
                                                               For reprints contact: service@oaepublish.com
              DOI:
              10.20517/2394-5079.2016.02                        How to cite this article: Bakshi N, Singh K. Diet and nutrition therapy
                                                                in pre-liver transplant patients. Hepatoma Res 2016;2:207-15.
                 © 2016 Hepatoma Research | Published by OAE Publishing Inc.                              207
   211   212   213   214   215   216   217   218   219   220   221